# KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer

> **NCT02168179** · NA · WITHDRAWN · sponsor: **Wake Forest University Health Sciences**

## Conditions studied

- Ductal Breast Carcinoma in Situ
- Skin Reactions Secondary to Radiation Therapy
- Stage IA Breast Cancer
- Stage IB Breast Cancer
- Stage IIA Breast Cancer
- Stage IIB Breast Cancer
- Stage IIIA Breast Cancer

## Interventions

- **PROCEDURE:** dermatologic complications management/prevention
- **OTHER:** questionnaire administration

## Key facts

- **NCT ID:** NCT02168179
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-12
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No longer pursuing study at our site.
- **Last updated:** 2018-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02168179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02168179, "KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02168179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*